Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
Regional Nerve Blocks for Middle Ear Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With GRADE Assessment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alzmmam Abdulrahman, Alshahrani Asma, Abualjamal Rena, Aljumah Maria, Bahattab Shahad, Aldubayyan Abdulsalam, Fida Zaid, Alissa Ghadah, Al Misnid Omar
Аннотация
OBJECTIVE: Middle ear surgery is frequently associated with significant postoperative pain, nausea, and vomiting. Such issues have prompted clinicians to adopt regional nerve blocks, such as the superficial cervical plexus block (SCPB) and the great auricular nerve block (GANB). Our aim was to evaluate the efficacy of regional nerve blocks in adult patients undergoing different middle ear surgeries.
DATABASES REVIEWED: PubMed, the Cochrane Central Database of Controlled Trials and Systematic Reviews (CDSR), Scopus, Web of Science, and Google Scholar.
METHODS: Eligible randomized controlled trials (RCTs) used targeted nerve blocks (SCPB or GANB) against a sham block (saline) or standard care in adults undergoing middle ear surgery. Outcomes evaluated included pain scores, opioid consumption, rescue analgesics, postoperative nausea and vomiting (PONV), and adverse events (vertigo, dizziness, and tinnitus). Non-RCTs, pediatric/animal studies, and trials comparing 2 active blocks were excluded.
RESULTS: A total of 7 RCTs with 459 participants were included in this review. Regional nerve block significantly reduced postoperative pain at 1, 12, and 24 hours (MDs=-0.80, -0.78, and -0.41, respectively; all P <0.0001). In addition, there was a significant reduction in intraoperative remifentanil consumption (MD=-531.18 µg) and a lower incidence of PONV (RR=0.46). Reductions in rescue analgesic requirements and differences in the incidence of adverse events were not statistically significant.
CONCLUSIONS: SCPB and GANB represent a promising adjunct in perioperative care for middle ear surgery, offering better pain management and enhanced patient recovery. Further optimization of these techniques is key to ensuring all patients receive the best perioperative care.
DATABASES REVIEWED: PubMed, the Cochrane Central Database of Controlled Trials and Systematic Reviews (CDSR), Scopus, Web of Science, and Google Scholar.
METHODS: Eligible randomized controlled trials (RCTs) used targeted nerve blocks (SCPB or GANB) against a sham block (saline) or standard care in adults undergoing middle ear surgery. Outcomes evaluated included pain scores, opioid consumption, rescue analgesics, postoperative nausea and vomiting (PONV), and adverse events (vertigo, dizziness, and tinnitus). Non-RCTs, pediatric/animal studies, and trials comparing 2 active blocks were excluded.
RESULTS: A total of 7 RCTs with 459 participants were included in this review. Regional nerve block significantly reduced postoperative pain at 1, 12, and 24 hours (MDs=-0.80, -0.78, and -0.41, respectively; all P <0.0001). In addition, there was a significant reduction in intraoperative remifentanil consumption (MD=-531.18 µg) and a lower incidence of PONV (RR=0.46). Reductions in rescue analgesic requirements and differences in the incidence of adverse events were not statistically significant.
CONCLUSIONS: SCPB and GANB represent a promising adjunct in perioperative care for middle ear surgery, offering better pain management and enhanced patient recovery. Further optimization of these techniques is key to ensuring all patients receive the best perioperative care.